EN | FR
EN | FR
Search

Breathing Life into Nanodrug Research: A Lung-on-Chip Revolution

When it comes to inhaled therapies, one of the biggest challenges is replicating the complex dynamics of human breathing in a controlled lab setting. Traditional aerosol exposure systems often fall short—they can deliver particles, but they don’t mimic the realistic airflow patterns and mucociliary clearance that define our respiratory system.

Comparative Analysis of Combustible and Electronic Cigarette Exposure

Combustible and Electronic Cigarette

While combustible cigarette smoke (CCS) is a well-established carcinogen, the oncogenic potential of electronic cigarette vapor (ECV) remains underexplored. A recent study led by Dr. Moghaddam et al. at The University of Texas MD Anderson Cancer Center provides a rigorous comparative analysis of CCS and ECV exposure in a KRAS-mutant lung adenocarcinoma (KM-LUAD) mouse model.

Longitudinal Studies with SCIREQ Systems

Longitudinal studies offer a wealth of information, particularly for diseases progression or development studies. In addition, smaller sample sizes are possible to accumulate significant data, as subject assessment is possible at multiple time points.

Animal Models for Pulmonary Diseases

Animal models are crucial in advancing our knowledge and understanding of pulmonary diseases. Using alternatives models, such as computer simulations, is simply not advanced enough to elucidate all the biological mechanisms inside a living creature.

Insights From SOT 2021!

SCIREQ recently attended this year’s Society of Toxicology (SOT 2021) Annual Meeting and ToxExpo! While the toxicological science of drugs of abuse has not been a major theme at previous SOT conferences, this year’s virtual event